ASO作者反思：一次有益，两次是否同样有益？对复发性CRS-HIPEC治疗结直肠癌腹膜转移的批判性评估 - Suppr

Suppr

超能文献

ASO Author Reflections: If Once Is Good, Is Twice Just as Good? A critical evaluation of Repeat CRS-HIPEC for Colorectal Peritoneal Metastases.

作者信息

Laks S, Adileh M, Ben-Yaacov A, Nissan A

机构信息

Department of General and Oncological Surgery - Surgery C, Chaim Sheba Medical Center, Ramat Gan, Israel.

出版信息

Ann Surg Oncol. 2021 Sep;28(9):5339-5340. doi: 10.1245/s10434-021-09704-6. Epub 2021 Feb 18.

DOI:10.1245/s10434-021-09704-6

PMID:33604829

Abstract

摘要

相似文献

ASO Author Reflections: If Once Is Good, Is Twice Just as Good? A critical evaluation of Repeat CRS-HIPEC for Colorectal Peritoneal Metastases.ASO作者反思：一次有益，两次是否同样有益？对复发性CRS-HIPEC治疗结直肠癌腹膜转移的批判性评估

Ann Surg Oncol. 2021 Sep;28(9):5339-5340. doi: 10.1245/s10434-021-09704-6. Epub 2021 Feb 18.

ASO Author Reflections: Pathologic Response Ratio (PRR) in CRS and HIPEC for Peritoneal Metastasis from Colorectal Cancer.ASO作者反思：结直肠癌腹膜转移的CRS和HIPEC中的病理反应率（PRR）

Ann Surg Oncol. 2021 Dec;28(13):9148-9149. doi: 10.1245/s10434-021-10369-4. Epub 2021 Jun 27.

ASO Author Reflections: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).ASO作者反思：微卫星和RAS/RAF突变状态作为接受减瘤手术和腹腔内热灌注化疗（HIPEC）治疗的结直肠癌腹膜转移的预后因素

Ann Surg Oncol. 2022 Jun;29(6):3418-3419. doi: 10.1245/s10434-021-11057-z. Epub 2021 Nov 6.

ASO Author Reflections: To Redo or Not to Redo, That is the Question: Assessing the Slings and Arrows of Repeat CRS/HIPEC in Patients with Recurrent or Progressive Peritoneal Carcinomatosis.ASO作者反思：重做还是不重做，这是个问题：评估复发性或进行性腹膜癌患者再次接受细胞减灭术和热灌注化疗所面临的种种困难。

Ann Surg Oncol. 2020 Dec;27(13):4892-4893. doi: 10.1245/s10434-020-08491-w. Epub 2020 Apr 21.

Neoadjuvant chemotherapy followed by hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastasis: a retrospective study of its safety and efficacy.新辅助化疗联合腹腔热灌注化疗治疗结直肠腹膜转移患者的安全性和有效性：一项回顾性研究。

World J Surg Oncol. 2021 May 17;19(1):151. doi: 10.1186/s12957-021-02255-w.

ASO Author Reflections: Significance of Primary Tumor Location and Genomic Alterations in Colorectal Peritoneal Metastases and Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy.ASO作者反思：原发性肿瘤位置和基因组改变在结直肠癌腹膜转移及细胞减灭术-热灌注化疗中的意义

Ann Surg Oncol. 2023 Jul;30(7):4471-4472. doi: 10.1245/s10434-023-13522-3. Epub 2023 Apr 27.

ASO Author Reflections: Palliative Management of Peritoneal Metastasis Exploring the Risks and Benefits of CRS/HIPEC, a Distinctly Different Context Than Early CRS/HIPEC Intervention With 'Curative Intent'.ASO作者反思：腹膜转移的姑息治疗——探索CRS/HIPEC的风险与益处，这与具有“治愈意图”的早期CRS/HIPEC干预背景截然不同。

Ann Surg Oncol. 2022 May;29(5):3347-3348. doi: 10.1245/s10434-022-11377-8. Epub 2022 Feb 25.

ASO Author Reflections: HIPEC Immunogenic Changes Could be Further Exploited by Immunotherapy to Treat Peritoneal Metastases from Colorectal Cancer.ASO作者反思：热灌注化疗的免疫原性变化可通过免疫疗法进一步利用，以治疗结直肠癌的腹膜转移。

Ann Surg Oncol. 2023 May;30(5):2664-2665. doi: 10.1245/s10434-023-13254-4. Epub 2023 Feb 17.

ASO Author Reflections: Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity Score Analysis.ASO作者反思：全身化疗对接受减瘤手术和热灌注化疗（HIPEC）治疗的结直肠癌腹膜转移患者是否有用？一项倾向评分分析。

Ann Surg Oncol. 2024 Mar;31(3):2008-2009. doi: 10.1245/s10434-023-14468-2. Epub 2023 Oct 18.

[Meta analysis of whether cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy can improve survival in patients with colorectal cancer peritoneal metastasis].[关于减瘤手术联合腹腔热灌注化疗能否改善结直肠癌腹膜转移患者生存率的Meta分析]

Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Mar 25;24(3):256-263. doi: 10.3760/cma.j.cn.441530-20201111-00604.

本文引用的文献

Perioperative and Oncological Outcomes of Combined Hepatectomy with Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer.联合肝切除与完全减瘤术和腹腔内热灌注化疗治疗转移性结直肠癌的围手术期和肿瘤学结果。

Ann Surg Oncol. 2021 Jun;28(6):3320-3329. doi: 10.1245/s10434-020-09165-3. Epub 2020 Sep 23.

Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.腹腔内热灌注化疗的细胞减灭术适应证及短期疗效的变化趋势。

Am J Surg. 2020 Mar;219(3):478-483. doi: 10.1016/j.amjsurg.2019.09.017. Epub 2019 Sep 19.

Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database.接受全身治疗的腹膜转移性结直肠癌患者的预后：来自消化系统癌症分析和研究（ARCAD）数据库的前瞻性随机试验的个体患者数据的分析。

Lancet Oncol. 2016 Dec;17(12):1709-1719. doi: 10.1016/S1470-2045(16)30500-9. Epub 2016 Oct 12.

Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.结直肠癌源性腹膜癌转移：发病率及当前治疗策略

Ann Surg. 2006 Feb;243(2):212-22. doi: 10.1097/01.sla.0000197702.46394.16.

Treatment of peritoneal carcinomatosis from colon or appendiceal cancer with induction intraperitoneal chemotherapy.采用诱导性腹腔内化疗治疗结肠癌或阑尾癌所致的腹膜癌病。

Cancer Treat Res. 1996;82:317-25. doi: 10.1007/978-1-4613-1247-5_20.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验